Previous close | 3.9000 |
Open | 5.0000 |
Bid | 4.4000 |
Ask | 5.1000 |
Strike | 270.00 |
Expiry date | 2024-06-21 |
Day's range | 3.9000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 389 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
On May 15, 2024, James Edgemond, the Chief Financial Officer and Treasurer of United Therapeutics Corp (NASDAQ:UTHR), sold 40,160 shares of the company.
On May 15, 2024, Director Christopher Causey sold 2,000 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing.